Experience compiled from nearly half a million women suggests that breast self-examination has a negligible effect in reducing breast cancer-related deaths. The practice may even be putting an unnecessary strain on breast care resources, according to researchers in Denmark.
Experience compiled from nearly half a million women suggests that breast self-examination has a negligible effect in reducing breast cancer-related deaths. The practice may even be putting an unnecessary strain on breast care resources, according to researchers in Denmark.
Reputed medical institutions as well as patient advocacy groups recommend that women give themselves a breast self-exam every month, starting by age 20, to check for lumps or other suspicious changes. Though palpation is widely praised as a valuable aid to early detection, a recent review of two large studies from Russia and China found no evidence that it could reduce breast cancer fatalities and concluded that it should not replace established screening methods, according to principal investigator Jan Peter Kosters, Ph.D.
"At present, screening by breast self-examination or physical examination [by a trained health worker] cannot be recommended," Kosters said.
Kosters and colleagues at the Nordic Cochrane Centre in Copenhagen analyzed data from 388,535 women. The investigators found that the women in the cohort who did breast self-exams had almost twice as many false-positive biopsies compared with women who did not perform the exams. They published their findings in the latest issue of The Cochrane Library.
Women who performed the palpation test had 3406 biopsies, whereas those who did not had only 1856 biopsies. The difference in the breast cancer death rate between the two groups was not statistically significant. The Chinese study also compared breast cancer management strategies from the self-exam versus the no-exam groups and found that rates of mastectomy and breast-conserving surgery were similar.
Study findings do not mean that women should stop using the self-evaluation technique, and researchers realize that some women will want to continue performing breast palpation exams. Women should always seek medical advice, however, if they detect any change in their breasts, Kosters said.
"We suggest that the lack of supporting evidence should be discussed with these women to enable them to make an informed decision," he said.
For more information from the Diagnostic Imaging archives:
MR elastography shakes up assumptions about body MR
Ultrasound manufacturers address patient care with product innovations
Breast elastography techniques break new ground
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.